Engineered albumin helps a therapeutic protein last longer and cross mucosal barriers

InsectNews.com brief · 3h ago · 1 min read · via phys.org

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream. For patients who depend on long-term or lifelong treatment, frequent

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream. For patients who depend on long-term or lifelong treatment, frequent This story matters for Science & Discovery readers tracking insect. Reported by phys.org. Read the full original at the source link below.

Originally reported by phys.org. InsectNews.com curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily insect signal

More from InsectNews.com

Related ventures